6-Fluoro-3,4-dihydro-3-oxo-2-pyrazinecarboxamide

Synonym
Product Category
Product Code
CAS Number
MDL Number
Pubchem CID
Reaxys RN
Favipiravir,T-705,Avigan,Favipira, Favilavir
API & Intermediates
KAPI1F28
259793-96-9
MFCD12032148
492405
9697246
image-155171-Trimethyl(trifluoromethyl)silane_reagent.png
Chemical Name
Molecular Formula
Molecular Weight
Assay
Appearance
Melting Point
Packaging
Storage
6-Fluoro-3,4-dihydro-3-oxo-2-pyrazinecarboxamide
C5H5FN3O2
157.10
≥97%
White to Light Yellow Solid
176-178°C
5g,10g,20g,50g,100g,500g and 1kg
Store at 2-8°C temp.
 6-Fluoro-3,4-dihydro-3-oxo-2-pyrazinecarboxamide (also known as Favipiravir, Favipira, Favilavir, Avigan, T-705) is a unique viral RNA Polymerase inhibitor for the treatment of Influenza ( experimental treatment of the emergent COVID-19 in 2020), acting on viral genetic copying to prevent its reproduction.
Favipiravir (T-705), a novel viral RNA polymerase inhibitor. [1]
A practical and step-economic route to Favipiravir. [2]
The complete synthesis of favipiravir from 2-aminopyrazine. [3]
References:
[1] Y.Furuta, et al, Antiviral Res., 2013, 100(2), pp 446-454.
[2] F.Liu, et al, Chem. Pap., 2017, 71(3), pp 1-6.
[3] Q.Guo, et al, Chem. Pap., 2019, 73(5), pp 1043-1051.
Signal Word
Hazard Statements
Precautionary Statements
HS Code
RIDADR
Legal Information
Warning
H302,H315,H319,H335
P261,P305+P351+P338
2933998090
NONH for all modes of transport
Limitation may apply to Sale.
1. Product Specification
Available on request.
2. Safety Data Sheet
Available on request.
Please inquire for pricing and availability of this product by writing email to sales@kumidas.com.